$ACAN
AmeriCann, Inc.

2020 Q3 Form 10-K Financial Statement

#000143774920025713 Filed on December 21, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 2019 Q3
Revenue $287.6K $503.5K $11.56K
YoY Change 2387.54% 4254.13%
Cost Of Revenue $22.50K
YoY Change
Gross Profit $481.0K
YoY Change
Gross Profit Margin 95.53%
Selling, General & Admin $895.7K $690.1K $2.016M
YoY Change -55.56% -79.73% 280.3%
% of Gross Profit 143.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $112.8K $446.9K $230.00
YoY Change 48934.78% 38689.41%
% of Gross Profit 92.9%
Operating Expenses $895.7K $667.6K $2.016M
YoY Change -55.56% -80.39% 280.3%
Operating Profit -$186.6K
YoY Change -94.5%
Interest Expense -$209.7K -$522.8K -$270.8K
YoY Change -22.59% -1.64% -15.36%
% of Operating Profit
Other Income/Expense, Net -$522.8K $0.00
YoY Change -65.42%
Pretax Income -$817.8K -$709.3K -$3.252M
YoY Change -74.85% -85.53% 282.59%
Income Tax
% Of Pretax Income
Net Earnings -$817.8K -$709.3K -$3.252M
YoY Change -74.85% -85.53% 282.59%
Net Earnings / Revenue -284.38% -140.88% -28131.49%
Basic Earnings Per Share
Diluted Earnings Per Share -$34.79K -$30.18K -$139.2K
COMMON SHARES
Basic Shares Outstanding 23.50M 23.41M
Diluted Shares Outstanding 23.50M

Balance Sheet

Concept 2020 Q3 2020 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $183.0K $183.0K $465.8K
YoY Change -60.71% -60.71% 132.92%
Cash & Equivalents $183.0K $183.0K $455.8K
Short-Term Investments
Other Short-Term Assets $12.65K $12.65K $897.8K
YoY Change -98.59% -98.59% -76.92%
Inventory
Prepaid Expenses
Receivables $124.6K $124.6K $11.56K
Other Receivables $37.16K $37.16K $32.27K
Total Short-Term Assets $357.4K $357.4K $1.407M
YoY Change -74.6% -74.6% -65.52%
LONG-TERM ASSETS
Property, Plant & Equipment $7.512M $14.43M $7.573M
YoY Change -0.8% 90.5% 130600.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $2.669M
YoY Change -100.0% -100.0% -2.23%
Total Long-Term Assets $14.51M $14.51M $10.36M
YoY Change 40.07% 40.07% 92.72%
TOTAL ASSETS
Total Short-Term Assets $357.4K $357.4K $1.407M
Total Long-Term Assets $14.51M $14.51M $10.36M
Total Assets $14.87M $14.87M $11.77M
YoY Change 26.35% 26.35% 24.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.00K $65.00K $265.3K
YoY Change -75.5% -75.5% -1.75%
Accrued Expenses $77.62K $77.62K $121.9K
YoY Change -36.31% -36.31% 143.76%
Deferred Revenue
YoY Change
Short-Term Debt $150.3K $150.3K $385.0K
YoY Change -60.97% -60.97% -25.96%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $589.6K $589.6K $781.3K
YoY Change -24.53% -24.54% -7.52%
LONG-TERM LIABILITIES
Long-Term Debt $4.160M $4.160M $4.874M
YoY Change -14.65% -14.65% 173.82%
Other Long-Term Liabilities $4.243M $4.243M
YoY Change
Total Long-Term Liabilities $8.403M $8.403M $4.874M
YoY Change 72.41% 72.41% 173.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $589.6K $589.6K $781.3K
Total Long-Term Liabilities $8.403M $8.403M $4.874M
Total Liabilities $8.993M $8.993M $5.655M
YoY Change 59.02% 59.02% 115.27%
SHAREHOLDERS EQUITY
Retained Earnings -$18.72M -$18.01M
YoY Change 3.94% 37.41%
Common Stock $2.370K $2.351K
YoY Change 0.81% 6.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.873M $5.873M $6.111M
YoY Change
Total Liabilities & Shareholders Equity $14.87M $14.87M $11.77M
YoY Change 26.35% 26.35% 24.41%

Cashflow Statement

Concept 2020 Q3 2020 2019 Q3
OPERATING ACTIVITIES
Net Income -$817.8K -$709.3K -$3.252M
YoY Change -74.85% -85.53% 282.59%
Depreciation, Depletion And Amortization $112.8K $446.9K $230.00
YoY Change 48934.78% 38689.41%
Cash From Operating Activities -$46.42K $518.3K -$1.128M
YoY Change -95.88% -123.68% 121.14%
INVESTING ACTIVITIES
Capital Expenditures -$5.840K -$386.5K -$1.184M
YoY Change -99.51% -93.44% 141.55%
Acquisitions
YoY Change
Other Investing Activities $7.760K $29.25K $6.010K
YoY Change 29.12% 4.46% -160.1%
Cash From Investing Activities $1.920K -$357.2K -$1.178M
YoY Change -100.16% -93.91% 135.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 150.0K -$1.260M 3.591M
YoY Change -95.82% -123.66% -3.21%
NET CHANGE
Cash From Operating Activities -46.42K $518.3K -1.128M
Cash From Investing Activities 1.920K -$357.2K -1.178M
Cash From Financing Activities 150.0K -$1.260M 3.591M
Net Change In Cash 105.5K -$1.099M 1.286M
YoY Change -91.79% -59.67% -52.39%
FREE CASH FLOW
Cash From Operating Activities -$46.42K $518.3K -$1.128M
Capital Expenditures -$5.840K -$386.5K -$1.184M
Free Cash Flow -$40.58K $904.8K $55.78K
YoY Change -172.75% -75.55% -378.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
4903668
CY2019 acan Class Of Warrant Or Right Granted During Period Exercise Price
ClassOfWarrantOrRightGrantedDuringPeriodExercisePrice
1.33
CY2020 acan Amortization Of Equity Instruments Issued To Lessor
AmortizationOfEquityInstrumentsIssuedToLessor
CY2019 acan Amortization Of Equity Instruments Issued To Lessor
AmortizationOfEquityInstrumentsIssuedToLessor
39460
CY2020Q3 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
9638650
CY2020Q3 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
1.39
CY2020 acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P1Y182D
CY2019 acan Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
388000
CY2020 acan Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
1600000
CY2019 acan Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
1.23
CY2020 acan Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
2.25
CY2019 acan Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
2148000
CY2018 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y219D
CY2019 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y109D
CY2020 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y292D
CY2020 acan Debt Discount Related To Warrants Issued With Debt And Beneficial Conversion Feature
DebtDiscountRelatedToWarrantsIssuedWithDebtAndBeneficialConversionFeature
CY2019 acan Debt Discount Related To Warrants Issued With Debt And Beneficial Conversion Feature
DebtDiscountRelatedToWarrantsIssuedWithDebtAndBeneficialConversionFeature
615154
CY2020Q3 acan Deferred Tax Assets Other Temporary Difference Tax Effect
DeferredTaxAssetsOtherTemporaryDifferenceTaxEffect
205002
CY2019Q3 acan Deferred Tax Assets Other Temporary Difference Tax Effect
DeferredTaxAssetsOtherTemporaryDifferenceTaxEffect
-433209
CY2020Q3 acan Deferred Tax Assets Tax Effect Gross
DeferredTaxAssetsTaxEffectGross
400073
CY2019Q3 acan Deferred Tax Assets Tax Effect Gross
DeferredTaxAssetsTaxEffectGross
776036
CY2020Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss
DeferredTaxAssetsTaxEffectNetOperatingLoss
174144
CY2019Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss
DeferredTaxAssetsTaxEffectNetOperatingLoss
1209245
CY2020Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss And Other Temporary Differences
DeferredTaxAssetsTaxEffectNetOperatingLossAndOtherTemporaryDifferences
379146
CY2019Q3 acan Deferred Tax Assets Tax Effect Net Operating Loss And Other Temporary Differences
DeferredTaxAssetsTaxEffectNetOperatingLossAndOtherTemporaryDifferences
776036
CY2020Q3 acan Deferred Tax Assets Tax Effect Valuation Allowance
DeferredTaxAssetsTaxEffectValuationAllowance
400073
CY2019Q3 acan Deferred Tax Assets Tax Effect Valuation Allowance
DeferredTaxAssetsTaxEffectValuationAllowance
776036
CY2020Q3 acan Deferred Tax Assets Tax Impact True Up Temporary Difference Tax Effect
DeferredTaxAssetsTaxImpactTrueUpTemporaryDifferenceTaxEffect
20927
CY2019Q3 acan Deferred Tax Assets Tax Impact True Up Temporary Difference Tax Effect
DeferredTaxAssetsTaxImpactTrueUpTemporaryDifferenceTaxEffect
CY2020Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
1544383
CY2019Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
3146942
CY2020Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
709343
CY2020Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
835040
CY2019Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
-1756726
CY2020Q3 acan Deferred Tax Assets Temporary Difference Tax Impact True Up
DeferredTaxAssetsTemporaryDifferenceTaxImpactTrueUp
CY2019Q3 acan Deferred Tax Assets Temporary Difference Tax Impact True Up
DeferredTaxAssetsTemporaryDifferenceTaxImpactTrueUp
CY2020Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
1544383
CY2019Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
3146942
CY2020 acan Deferred Tax Assets Valuation Allowance Percent Offset
DeferredTaxAssetsValuationAllowancePercentOffset
1
CY2020Q3 acan Depoists On Land Noncurrent
DepoistsOnLandNoncurrent
CY2019Q3 acan Depoists On Land Noncurrent
DepoistsOnLandNoncurrent
2666129
CY2020 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.2455
CY2019 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.2466
CY2020 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.2455
CY2019 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.2466
CY2020 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
13962
CY2019 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
25993
CY2020 acan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8917
CY2019 acan Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2020 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
113053
CY2019 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
11564
CY2020Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
26246
CY2019Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
12283
CY2020Q3 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
119512
CY2019Q3 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
148763
CY2020Q3 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
37165
CY2019Q3 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
32270
CY2020 acan Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
256125
CY2020 acan Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
66877
CY2019 acan Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
CY2014Q1 acan Ownership Percentage Transfered
OwnershipPercentageTransfered
0.93
CY2020 acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
386487
CY2019 acan Payments To Acquire Property Plant And Equipment Excluding Construction In Progress
PaymentsToAcquirePropertyPlantAndEquipmentExcludingConstructionInProgress
5889794
CY2020 acan Proceeds From Warrant Exercises Net
ProceedsFromWarrantExercisesNet
CY2019 acan Proceeds From Warrant Exercises Net
ProceedsFromWarrantExercisesNet
475500
CY2020Q3 acan Property Lease Unearned Revenue
PropertyLeaseUnearnedRevenue
0
CY2019Q3 acan Property Lease Unearned Revenue
PropertyLeaseUnearnedRevenue
0
CY2020Q3 acan Security Deposit And Other Noncurrent Assets
SecurityDepositAndOtherNoncurrentAssets
CY2019Q3 acan Security Deposit And Other Noncurrent Assets
SecurityDepositAndOtherNoncurrentAssets
3110
CY2019 acan Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P4Y292D
CY2020 acan Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P5Y
CY2019 acan Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
388000
CY2019 acan Stock Issued During Period Value Issued For Cash Net
StockIssuedDuringPeriodValueIssuedForCashNet
1211000
CY2019 acan Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
475500
CY2020Q3 acan Tenant Receivable Current
TenantReceivableCurrent
124617
CY2019Q3 acan Tenant Receivable Current
TenantReceivableCurrent
11564
CY2020Q3 acan Working Capital Deficit
WorkingCapitalDeficit
-232158
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001508348
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23696310
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Public Float
EntityPublicFloat
7281000
CY2020 dei Entity Registrant Name
EntityRegistrantName
Americann, Inc.
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12g Title
Security12gTitle
Common Stock, ($0.001 Par Value)
CY2020 dei Trading Symbol
TradingSymbol
acan
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
276155
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
265276
CY2020Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
65000
CY2019Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
448006
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1152
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24593485
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24121534
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
615154
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
488793
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
381970
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
977110
CY2019Q3 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
1761675
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
311370
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
171628
CY2020Q3 us-gaap Assets
Assets
14866289
CY2019Q3 us-gaap Assets
Assets
11766007
CY2020Q3 us-gaap Assets Current
AssetsCurrent
357441
CY2019Q3 us-gaap Assets Current
AssetsCurrent
1407487
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
183009
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
455843
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1292062
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4016949
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193159
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1098903
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2724887
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.55
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.52
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.39
CY2018Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9478650
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11238650
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9638650
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23696310
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23504820
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23696310
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23504820
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
2370
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
2351
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;">Concentration of Credit Risks and Significant Customers</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, notes receivable, deposits tenant receviables and notes receivable. We place our cash with high credit quality financial institutions. As of <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>we had outstanding notes receivable of <div style="display: inline; font-style: italic; font: inherit;">$119,512</div> and tenant receivables of <div style="display: inline; font-style: italic; font: inherit;">$124,617</div> with BASK, Inc. ("BASK"), a related party. As of <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2019, </div>we had outstanding notes receivables of <div style="display: inline; font-style: italic; font: inherit;">$148,763</div> with BASK&nbsp;and a note and a receivable in the amount of <div style="display: inline; font-style: italic; font: inherit;">$1,761,675</div> with WGP (exclusive of provision for doubtful accounts of <div style="display: inline; font-style: italic; font: inherit;">$1,761,675</div>).&nbsp; Balance due from Wellness Group Pharms ("WGP") was collected in full in <div style="display: inline; font-style: italic; font: inherit;"> February 2020.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">For the year ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>all of the Company's revenue was earned from <div style="display: inline; font-style: italic; font: inherit;">one</div> customer, BASK. As of <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>the BASK tenant receivable balance was <div style="display: inline; font-style: italic; font: inherit;">$124,617.</div></div></div></div></div></div>
CY2020 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
CY2019 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
261513
CY2019 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
174342
CY2019 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
261513
CY2020Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
571483
CY2019Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
882603
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2019Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2838966
CY2019Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2438893
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2838966
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2438893
CY2020 us-gaap Depreciation
Depreciation
446854
CY2019 us-gaap Depreciation
Depreciation
1152
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
446854
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1152
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0355
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0366
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3030
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-977110
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2007642
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1626596
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2019 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10879
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15710
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
65000
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-62950
CY2019 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
70798
CY2020 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
1761675
CY2019 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
11442
CY2019 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
223
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-14242
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6162
CY2020 us-gaap Interest Expense Other
InterestExpenseOther
760704
CY2019 us-gaap Interest Expense Other
InterestExpenseOther
426424
CY2020 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
95766
CY2019 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
134167
CY2020 us-gaap Interest Paid Net
InterestPaidNet
594088
CY2019 us-gaap Interest Paid Net
InterestPaidNet
286244
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
72895
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
121883
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
333681
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
29109
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
90000
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
154998
CY2020Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.079
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15709000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
14001500
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
341500
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
341500
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
341500
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
341500
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
341500
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11461048
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P46Y
CY2020Q3 us-gaap Liabilities
Liabilities
8992986
CY2019Q3 us-gaap Liabilities
Liabilities
5655331
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14866289
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11766007
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
589599
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
781288
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
3578517
CY2019Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
3117397
CY2020 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
38179
CY2019 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
126993
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1260000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5325500
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-357236
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5861793
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
518333
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2188594
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-709343
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-4903668
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-522789
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1511622
CY2020Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0
CY2019Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
150250
CY2019Q3 us-gaap Notes Payable Current
NotesPayableCurrent
385000
CY2020Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
581646
CY2019Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1756646
CY2020Q3 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
37165
CY2019Q3 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
32270
CY2020Q3 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
82347
CY2019Q3 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
116493
CY2020 us-gaap Operating Expenses
OperatingExpenses
690066
CY2019 us-gaap Operating Expenses
OperatingExpenses
3403610
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-186554
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-3392046
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
401021
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
410162
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4256869
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4247952
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4728
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4243224
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6980957
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6914080
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2020 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
503512
CY2019 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
11564
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
11564017
CY2018Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10019634
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20571
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9129
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3030
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2500
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13632
CY2020Q3 us-gaap Prepaid Rent
PrepaidRent
0
CY2019Q3 us-gaap Prepaid Rent
PrepaidRent
57959
CY2020 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
29251
CY2019 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
28001
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1211000
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3910000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
475500
CY2020 us-gaap Professional Fees
ProfessionalFees
405920
CY2019 us-gaap Professional Fees
ProfessionalFees
866116
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7960427
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7573940
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7512421
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7572788
CY2019Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1761675
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1761675
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
783905
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
235000
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
271000
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1175000
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10150
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
836219
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18722552
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18013209
CY2020 us-gaap Revenues
Revenues
503512
CY2019 us-gaap Revenues
Revenues
11564
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6980957
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23504820
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
381970
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
488793
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
200000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
900000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1000000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
150000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1050000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1850000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.21
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.64
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.99
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1850000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.99
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1850000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.99
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.50
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.50
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.25
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y328D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y146D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y73D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y73D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y73D
CY2019 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
119734
CY2020 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
191490
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
261513
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
154998
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5873303
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6110676
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
6830276
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect&nbsp;the&nbsp;reported&nbsp;amounts of assets and&nbsp;liabilities and disclosure of contingent&nbsp;assets and liabilities at the date of the consolidated financial statements and the&nbsp;reported amounts of revenues and expenses&nbsp;during the reporting period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of long-lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.&nbsp;&nbsp;</div></div></div></div></div></div></div>
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-400073
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-776036
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22984703
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23504820
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22984703
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23504820
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22984703

Files In Submission

Name View Source Status
0001437749-20-025713-index-headers.html Edgar Link pending
0001437749-20-025713-index.html Edgar Link pending
0001437749-20-025713.txt Edgar Link pending
0001437749-20-025713-xbrl.zip Edgar Link pending
acan-20200930.xml Edgar Link completed
acan-20200930.xsd Edgar Link pending
acan-20200930_cal.xml Edgar Link unprocessable
acan-20200930_def.xml Edgar Link unprocessable
acan-20200930_lab.xml Edgar Link unprocessable
acan-20200930_pre.xml Edgar Link unprocessable
acan20200930_10k.htm Edgar Link pending
ex_216460.htm Edgar Link pending
ex_216461.htm Edgar Link pending
ex_216462.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending